“As of April 2, 2021, 42 cases of a central venous / sinus vein thrombosis reported after vaccination with Vaxzevria.  In 23 Thrombocytopenia has also been reported in cases.

In one case where post mortem a central sinus vein thrombosis with cerebral hemorrhage was found, the platelet count could no longer be reliably determined. With the exception of seven cases, they affected all others. Cases in women aged 20 to 63 years. The men were 24 to 58 Year old. Eight patients (5 women, 3 men) died.

For some of the patients who have had post-vaccination sinus thrombosis with thrombocytopenia, high platelet antibodies  were found which are common with the clinical picture of a disease similar to an autoimmune one Heparin-induced thrombocytopenia (aHIT). And a HIT Thromboses can also occur without the administration of heparin.

The Paul Ehrlich Institute has numerically more case reports from Sinus vein thrombosis after vaccination with Vaxzevria in women before (83.3% vs. 16.7%), whereby young women were particularly often affected. However, according to the information provided by Robert Koch Institute, women were also vaccinated more often than men. There were significantly more cases for women aged 20-59 years observed than expected based on the background incidence.”

Report download (PDF):  Suspected side effects and vaccination complications after vaccination to protect against COVID-19 (Verdachtsfälle von Nebenwirkungen und Impfkomplikationen nach Impfung zum Schutz vor COVID-19)

Image by Michael Siebert from Pixabay